P Resting platelets have a loose reticular network of actin filaments beneath the membrane' that is linked to membrane components in part by actin-binding protein (ABP) and perhaps by talin (235-Kd) protein).'.' A portion of the ABP is found in a complex with the membrane glycoprotein (GP) Ib,3-6 a receptor for von Willebrand factor (vWf).'-I0 Lysis of resting platelets with Triton X-100 leaves a small insoluble protein residue, largely composed of filamentous actin which sediments a t relatively low g force (8,000 to 12,000 g)."." When platelets are stimulated with ADP or other agonists, they may undergo shape change, pseudopod extension, secretion, and aggregation, and assemble a cytoskeleton that contains numerous proteins of the contractile system other than a~t i n . ' * '~~'~, '~ Aggregation itself results from the binding to GPIIb/IIIa of fibrinogen or other ligands that then attach the platelets to one another.l6-I8 Aggregation, but not receptor occupancy alone, results in retention of GPIIIa in the cytoskeletal core.' 1~1'* 19 Agglutination induced by vWf has been believed to be a passive phenomenon because fixed or resting platelets in the presence of ristocetin bind human vWf to GPIb and a g g l~t i n a t e .~'~~ Bovine vWf acts on human platelets in a similar manner without ristocetin.z0-z2 Grant et alz3 and other inhibited with leupeptin. Platelet suspensions exposed t o bovine vWf without stirring (ie, nonagglutinated) or platelets in which agglutination was inhibited with ADP showed smaller cytoskeletons with little ABP. 235 Kd protein, and a-actinin. Autoradiographs showed mainly GPlb. Cytochalasin D (CD) and monobromobimane (MB) enhanced agglutination and prevented the inhibitory action of ADP on bovine vWf-induced platelet agglutination. CD markedly inhibited the assembly of the cytoskeletal core as well as GPllla retention, whereas MB resulted in a large Tritoninsoluble residue which contained GPllla. Thus, development of a platelet cytoskeletal core is apparently not required for agglutination, but when a cytoskeletal core is assembled in agglutinated platelets, GPllla is retained. 0 1990 by The American Society of Hematology.
researcher~'~ showed that ADP causes marked inhibition of vWf-induced agglutination. Inhibition does not require the presence of GPIIb/IIIa because it is observed with thrombasthenic platelet^."*'^ vWf-stimulated agglutination is also inhibited by agents that elevate cyclic AMP.22*25*z6 To our knowledge, formation of a cytoskeletal core in platelets that have bound vWf or have agglutinated has not been demonstrated, although CollerZ5 suggested that the ability of cytochalasin D to prevent prostaglandin E, (PGE,) inhibition and even to enhance agglutination may be mediated by its effect on the platelet cytoskeleton.
We examined the formation and composition of the cytoskeletal core and the retention of GPIIIa in (a) platelets that have agglutinated with bovine vWf, (b) platelets in which agglutination is inhibited by ADP, and (c) platelets in which ADP-induced inhibition of agglutination is prevented by cytochalasin D (CD) or the thiol reagent monobromobimane (MB).
MATERIALS AND METHODS
MB (Thiolyte) and CD were obtained from Calbiochem-Behring Diagnostics, San Diego, CA, Triton X-100 from J.T. Baker Chemical Co, Phillipsburg, NY; acetonitrile and dimethylsulfoxide (DMSO) from Pierce Chemical, Rockford, IL; leupeptin, apyrase, phenylmethylsulfonyl fluoride (PMSF) and acetylsalicylic acid (ASA) from Sigma Chemical, St Louis, MO, sodium dodecyl sulfate (SDS) and reagents for polyacrylamide gel electrophoresis (PAGE) from BioRad Laboratories, Richmond, CA; and Gel-Bond was obtained from FMC BioProducts, Rockland, ME. Bovine vWf was present in a bovine fibrinogen preparation (1.3 mg protein/mL, 70% clottable) from the American Red Cross Laboratory, Bethesda, MD, and represented 5% of the protein (calculated from its area on scans of SDS polyacrylamide gels). Monoclonal antibody (MoAb) 328 to the GPIb binding site on human vWf was from Dr Dominique Meyer, Hdpital de Bicstre, Paris, France.
MB was stored at 4OC as a 300 mmol/L solution in acetonitrile, and further dilutions were made so that the platelet suspensions contained no more than 0.5% acetonitrile. The following were stored at -2OOC: 10 mmol/L ADP, 1 mmol/L ASA and 10 mg/mL apyrase in isotonic saline and 2 mmol/L CD in 95% ethanol.
Blood was obtained from healthy normal adults who had given consent according to the Helsinki declaration. It was drawn through a 19-gauge needle attached by Preparation of platelets. For personal use only. on August 30, 2017. by guest www.bloodjournal.org From plastic tubing to a syringe containing one-ninth volume of 0.109 mol/L sodium citrate. Platelet-rich plasma (PRP) was separated and then incubated for 30 minutes with one-tenth volume of 1 mmol/L ASA. Platelets were collected by centrifugation and washed as previously described" except that the final suspension medium was buffered to pH 7. 4 with 10 mmol/L HEPES (N-2-hydroxyethylpiperazine-"-2 ethane sulfonic acid) and contained 0.1 mg/mL apyrase, 2 mg/mL bovine serum albumin, and no added CaZ+. For some studies, a portion of the suspension at pH 6.5 containing 1 x lo9 platelets was spun, resuspended in 1 mL buffer without apyrase or albumin, and labeled with I2'I using lactoperoxidase.z7 The labeled platelets were then diluted in HEPES-Tyrode solution with albumin, and 5 mmol/L EDTA, added to the unlabeled once washed platelets, centrifuged, and washed twice with this solution. Labeled platelets represented approximately 5% of the total number.
Platelet agglutination studies and preparation of the cytoskeletal core. Platelet agglutination in 0.6 mL ASA-treated washed platelet suspension (0.6 x 109/mL) was recorded with 5 mmol/L EDTA added at 37OC with an aggregometer (Payton Associates, Buffalo, NY, or Chrono-Log, Haverton, PA). The platelets were incubated with either 10 pmol/L ADP or saline for 1 minute before addition of 140 p L of the fibrinogen solution (9 pg bovine vWf). Inhibition was expressed as the percentage of decrease in the steepest slope of the agglutination curve. In experiments in which MB (250 pmol/L) or CD (10 pmol/L) was used to prevent ADP-induced inhibition, the reagents were added 1 minute before ADP was added. Two minutes after vWf was added, the suspension was mixed and vortexed with an equal volume of 2% Triton X-100, 100 mmol/L Tris, 10 mmol/L EGTA'Z.z8 often containing 20 pmol/L leupeptin and 0.5 mmol/L PMSF, and allowed to stand in ice for 10 minutes. The suspension was spun in an Eppendorf centrifuge (12,000 g), and the small sediment was washed twice by resuspending it in the same Triton solution diluted with an equal volume of isotonic saline. The sedimented cytoskeletal core was then dissolved in a solution containing 2% SDS, 20% glycerol, 100 mmol/L Tris, 5 mmol/L N-ethylmaleimide, 3 mmol/L EGTA and, in some experiments, 20 pmol/L leupeptin. The samples were placed in a boiling water bath for 3 to 5 minutes with or without 50 mmol/L dithiothreitol and frozen.
SDS-PAGE. Samples were electrophoresed according to the method of LaemmliZ9 on 7.5% polyacrylamide gels with 4.5% polyacrylamide in the stacking gel, cast on GelBond film, and stained with Coomassie brilliant blue. Gels containing '251-labeled platelets were dried and exposed for autoradiography." Each gel represents results in the Triton-insoluble residues from a single experiment, and equal volumes of each sample were applied to each lane. Each experiment was performed at least five times. Scanning densitometry (EC Densitometer, EC Apparatus, St Petersburg, FL, attached to a Hewlett Packard HP3396A Integrator, Purchase, NY) was used to estimate the proportions of cytoskeletal proteins in each lane of the gel.
Immunoblots were performed in the laboratory of Dr Simon Kar~atkin.~' Unreduced proteins were separated by 10% SDS-PAGE, transferred electrophoretically to unmodified nitrocellulose paper and were detected first with a human MoAb to PLA,, an antigen located on GPIIIa, and then with an alkaline phosphatase-labeled y-chain-specific anti-human IgG antibody.
Zmmunoblotting.

RESULTS
Formation of a cytoskeletal core in washed '251-labeled platelets agglutinated with vW$ Association of GPIIIa with the core. Agglutination was induced in these studies with bovine vWf instead of human vWf plus ristocetin because addition of ristocetin after Triton X-100 resulted in nonspecific precipitation of cytoskeletal proteins.
ASA-treated platelets agglutinated when stirred with bovine vWf and 5 mmol/L EDTA (Fig 1A) . The presence of leupeptin (260 pmol/L) did not influence the slope of agglutination.
Cytoskeletons made from platelets agglutinated with bovine vWf alone or with leupeptin added contained a welldeveloped cytoskeletal core consisting of ABP (260 Kd), a small band at 235 Kd (presumably talin), myosin heavy chain (200 Kd), a 100-Kd protein probably representing a-actinin, and actin (43 Kd) (Fig 2A, lanes c and d) .
Comparison of the amount of protein in cytoskeletons made from 7.2 x 10' platelets (Fig 2, lane c) with the total amount of protein in 5.4 x lo7 platelets (Fig 2, lanes a and b) indicates that the cytoskeleton consists of only a small portion of the total platelet protein. The proportion of each cytoskeletal protein in vWf-agglutinated samples was estimated from scans of the gels (Fig 3) . The total area of integration (measured as counts; one count equals 0.125 pV-s) was 5.2 x IO6 0.33 (+SE) (n = 9). Myosin and actin were the most abundant proteins, representing 10.3% k 1.5 (+SE) and 21.7% 4.2 (kSE), respectively. ABP and a-actinin were present in approximately equal amounts Triton-insoluble residues made from unstirred EDTAtreated platelets with bovine vWf added were about half the size of those made from stirred samples. The major constituents again were the heavy chain of myosin and actin (Fig 2.  lane h) . The percentage of ABP was only about 35% of that in thecoresof agglutinated platelets, and 235-Kd protein and a-actinin were not evident.
Four labeled membrane GPs were selectively associated with the cytoskeletal core of agglutinated platelets (Fig 28.  lanes c and d) . Their molecular weights (mol wt), estimated from scans of the autoradiographs, were 143, 132. 105. and 87 Kd. under reduced conditions, and 170, 143, 114, and 87 Kd in unreduced samples (not shown). These values correspond to the reported mol wt of GPslb, Ilb. Illa, and IV, respecti~ely.~' The identity of GPllla was confirmed by immunoblotting (Fig 4. lane d) . The proportion of these GPs varied in different experiments. When calculated from the total area of integration of autoradiographs in five experiments, it was 19.5% 2 4.26 (2SE) for GPlb: 11.5% 2 2.46 (+SE) for GPllb; 33.2% 2 5.6 (+SE) for GPllla; and 1 1.8% 2 I .5 (2SE) for GPIV. The cytoskeleton of unstirred vWf-treated platelets showed mainly GPlb (Fig 2B, lane h) .
Agglutination induced by bovine vWf was completely reversed on addition at 2 min of I I pg MoAb 328 (Fig IC) , a MoAb raised against the epitopeon human vWf that binds to GPlb>.3' SDS-PAGE showed that the cytoskeletal core was disassembled at 4 minutes (Fig 5, lane d) (Fig 2A and B. lanes i and j) samples. The amount of ABP incorporated into the cytoskeletal core correlated with the presence or absence of GPllla and with the degree of ADP-induced inhibition; eg, in an experiment in which ADP inhibited agglutination by 65%, ARP was decreased 25% and GPIlla was reduced 33%. When agglutination was inhibited by 85%, ABP was decreased 76%, with almost zero retention of GPllla in the Triton-insoluble residue.
Preincubation of platelets for I minute with 250 pmol/L MB or 10 pmol/L CD enhanced bovine vWf-induced agglutination (not shown) and prevented the inhibitory effect of ADP (Fig ID) . MB increased the amount of cytoskeletal protein and GPllla in platelets agglutinated after addition of ADP (Fig 6A and B. lanes f and g) or without it (Fig 7A and  B. lanes c and d) . In contrast, CD substantially decreased the amount of cytoskeletal protein and GPllla in platelets agglutinated with ADP (Fig SA and B. lane h) or without it (Fig 5A and B , lane c and Fig 7A and B, lane b) .
DISCUSSION
We and other researchers have shown that unstimulated platelets have a small Triton-insoluble residue composed tion of a larger cytoskeleton and cause incorporation of the fibrinogen receptor GPllb-llla into the cytoskeleton of anareaated platelets.".".iu Little attention has been Daid to ---determining whether occupancy of the platelet vWf receptor GPlb or agglutination results in the assembly of cytoskeleton. however.
the 2-minute and 4-minute cytoskeletons prepared from agglutinated samples (Fig 5. lanes a and b. respectively) . Disassembly of the cytoskeletons was accompanied by a marked decrease of GPllla, as shown by autoradiography (Fig 5R. lane d) .
Eflect of ADP and platelet inhibitors on formation of the cytoskeletal core of "'I-labeled platelets agglutinated with vWJ Association of GPIlla with the core. Incubation of ASA-treated washed platelets in the presence of EDTA for I min with 10 pmol/L ADP, alone or in the presence of 260 pmol/L leupeptin. inhibited vWf-induced agglutination by 8 I .3% f 3.84 (2SE) (n = 9) (Fig I B) . The total amount of cytoskeletal core was decreased 20% as compared with samples agglutinated in the absence of ADP (area estimated from scans was 4.1 x IOn 0.45 (+SE) (n = 9)). In contrast, the percentages of ABP, 235-Kd protein and a-actinin in the Triton-insoluble residues decreased between 40'70 and 60% (Fig 2A. lane e and Fig 3) . whereas the percentages of actin and myosin were similar to those for platelets agglutinated with vWf alone.
Autoradiography of the cytoskeletons made from platelets agglutinated with vWf in the presence of ADP (Fig 2B, lane  e) showed the presence of labeled GPlb, whereas the other labeled GPs, including GPllla. were greatly decreased or absent. An immunoblot confirmed the absence of GPllla (Fig 4, lane c) . Leupeptin had no effect on cytoskeletal assembly or GPllla retention in stirred (Fig 2A and B. lanes For Bovine vWf binds to GPlb on human platelets in the absence of ristoCetin.20.2' Our pressnt studies show that the Triton-insoluble residue or cytoskeleton of unstirred samples prepared with bovine vWf is composed mainly of myosin and actin. The amount of ABP is minimal and the 235-Kd protein and a-actinin are not evident. The large amount of myosin is attributable to the presence of EDTA, which causes rigor bonds to form between myosin and actin." The only GP incorporated into the cytoskeletal core of unstirred samples is GPlb. Other researchers showed that ABP is complexed with GPlb in both Triton-soluble and Triton-insoluble fractions of resting pIateIets."'."
Stirring labeled platelets with bovine vWf induces agglutination and the assembly of a larger cytoskeleton. The amount of actin and myosin in Triton-insoluble residues is about the same as in unstirred samples, but the amounts of ABP. 235-Kd protein, and a-actinin are markedly increased. Addition of MoAb 328 reverses agglutination as well as assembly of the cytoskeleton. Although MoAb 328 is made against the GPlb-binding domain of human vWf,g" it inhibits agglutination induced by bovine vWf. suggesting that this portion of the vWf molecule is very similar in both species.
The cytoskeleton of agglutinated platelets contained not only GPlb but also the GPllb-llla complex and a 87-Kd GP, probably GPIV. Thus, GPllla is incorporated into the cytoskeleton during agglutination, even though it presumably has no role in this, response. Because in these experiFor personal use only. on August 30, 2017. by guest www.bloodjournal.org From The association between GPllla and the cytoskeleton is accompanied by an increase in cytoskeletal ABP, 235-Kd protein, and a-actinin. Because only 20% of the total ABP pool is associated with GPlb,' a portion of the remaining ABP pool, either as such or modified, is available to react with other GPs. An association between ABP and GPllbllla has been noted previously.'' but the underlying mechanism is not known. ABP phosphorylation was proposed as a mechanism for modulating its affinity for actin." and a similar mechanism may operate to bind it toGPllb-llla.
The effects of the fungal metabolite CD and the thiol reagent MB were studied. The cytochalasins inhibit actin polymeriiation in platelets" and decrease cytoskeletal size.'" whereas MB. which binds to the thiol group of cytoskeletal proteins," increases the amount of the cytoskeleton.'' Both CD and MB increased vWf-induced platelet agglutination, but had different effects on the size of the Triton-insoluble residue and retention of GPllla: CD disassembled the cytoskeletal core with loss of GPllla retention, whereas M B increased the amount of cytoskeleton, especially ABP and 235-Kd protein, and enhanced retention of GPllla. Wheeler et allp observed that cytochalasin E decreased the size of the cytoskeleton and the incorporation of GPllla in platelets aggregated with phorbol myristate acetate. Because CD enhances agglutination and does not inhibit aggregation," it appears that formation of a large cytoskeleton containing GPllla is not necessarily associated with either agglutination or aggregation. Furthermore, the absence of Triton-insoluble GPI I la despite the marked agglutination indicates that the association of GPllla with the cytoskeleton of agglutinated platelets is not an artifactual result of trapping of unlysed membranes in the large clumps.2x
Pretreatment of platelets with ADP inhibits agglutination induced by bovine vWf or human vWf plus ristocetin." The mechanism of this inhibition is unclear, as ADP does not decrease the amount"." or multimer size of platelet-bound vWf." Inhibition is accompanied by decreased incorporation into the cytoskeleton of ARP. 235-Kd protein, and a-actinin.
This decrease does not result from proteolysis of these calpain-sensitive proteins,'".'' because it was not prevented by leupeptin. Both MB and CD reverse or prevent ADPinduced inhibition of platelet agglutination, but, as in the absence of ADP, MB enhances cytoskeletal assembly and GPllla retention, whereas CD has the opposite elfect?
The present studies establish that platelet agglutination induced by vWf is not a passive event because it is usually accompanied by changes in the organkation and assembly of the cytoskeletal components, as well as in their association with GPllla and other GPs.
